Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -227.67% is 166% below its 5-year average of -85.71%, near the low end of its 5-year range (-245.39%–-15.60%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.07% below its 12-month average of -183.51%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -227.67%.
RETURN ON INVESTED CAPITAL (ROIC)
-227.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-183.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-125.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-85.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-24.07%
CURRENT VS 3Y AVG
-80.85%
CURRENT VS 5Y AVG
-165.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-538.71%
vs the sector median at left
Senti Biosciences, Inc.
Market Cap
$10.30M
Return on Invested Capital (ROIC)
-227.67%
TTM Avg
-183.51%
3Y Avg
-125.89%
5Y Avg
-85.71%
Market Cap
$10.39M
Return on Invested Capital (ROIC)
-59.35%
TTM Avg
-68.11%
3Y Avg
-104.39%
5Y Avg
-133.77%
Market Cap
$10.41M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-47.37%
3Y Avg
-38.90%
5Y Avg
-35.62%
Market Cap
$10.18M
Return on Invested Capital (ROIC)
-323.71%
TTM Avg
-133.57%
3Y Avg
-246.04%
5Y Avg
-170.10%
Market Cap
$10.10M
Return on Invested Capital (ROIC)
-269.16%
TTM Avg
-387.93%
3Y Avg
-400.47%
5Y Avg
-400.47%
Market Cap
$10.10M
Return on Invested Capital (ROIC)
-95.42%
TTM Avg
-108.10%
3Y Avg
-72.41%
5Y Avg
-59.15%
Market Cap
$10.80M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-27.20%
3Y Avg
-100.49%
5Y Avg
-187.87%
Market Cap
$10.68M
Return on Invested Capital (ROIC)
-127.37%
TTM Avg
-96.60%
3Y Avg
-79.17%
5Y Avg
-74.39%
Market Cap
$9.62M
Return on Invested Capital (ROIC)
-215.61%
TTM Avg
-191.09%
3Y Avg
-141.72%
5Y Avg
-179.96%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Senti Biosciences, Inc. (SNTI) | $10.30M | -227.67% | -183.51% | -125.89% | -85.71% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.39M | -59.35% | -68.11% | -104.39% | -133.77% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.41M | N/A | -47.37% | -38.90% | -35.62% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | -323.71% | -133.57% | -246.04% | -170.10% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | -269.16% | -387.93% | -400.47% | -400.47% |
| Lifeward Ltd. (LFWD)vs › | $10.10M | -95.42% | -108.10% | -72.41% | -59.15% |
| Polyrizon Ltd. (PLRZ)vs › | $10.80M | N/A | -27.20% | -100.49% | -187.87% |
| Pluri Inc. (PLUR)vs › | $10.68M | -127.37% | -96.60% | -79.17% | -74.39% |
| MetaVia Inc. (MTVA)vs › | $9.62M | -215.61% | -191.09% | -141.72% | -179.96% |
| Valion Bio, Inc. (VBIO)vs › | $9.82M | -55.13% | -99.85% | -167.97% | -308.25% |
ROIC
-227.7%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -227.67% |
| 2026-03-31 | -245.39% |
| 2025-12-31 | -171.08% |
| 2025-09-30 | -163.09% |
| 2025-06-30 | -110.29% |
| 2025-03-31 | -84.85% |
| 2024-12-31 | -72.07% |
| 2024-09-30 | -130.09% |
| 2024-06-30 | -118.13% |
| 2024-03-31 | -101.31% |
| 2023-12-31 | -86.56% |
| 2023-09-30 | -77.31% |
| 2023-06-30 | -48.73% |
| 2023-03-31 | -48.13% |
| 2022-12-31 | -41.96% |
| 2022-09-30 | -34.08% |
| 2022-06-30 | -30.25% |
| 2022-03-31 | -18.98% |
| 2021-12-31 | -48.21% |
| 2021-09-30 | -15.60% |
